Company intelligence / Profile preview

Healium Medical

Yokneam, Israel

Ownership: Private
Development stage: Other

Overview

Healium Medical has developed the Echomplish RDN Ablation System, a no-contact guided ultrasound ablation technology that allows simultaneous tissue ablation and lesion monitoring. The company has received recognition including the 1st prize of the ICI 2019 Innovation award and a €12.75M EIC Accelerator 2021 Award. As of September 2022, the company entered into a strategic cooperation with Broncus Holding Corporation to integrate their technologies for lung cancer treatment applications.[1][4]

Therapeutic areas: OncologyCardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Broncus Holding Corporation (2216.HK)

Beyond the preview

Go deeper on Healium Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Healium Medical.

Explore the full profile